Brain And Neuroimaging Devices Market Outlook 2024: Exclusive Report By The Business Research Company | GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, Medtronic Plc., EB Neuro S.p.A., Neurosoft,

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Brain And Neuroimaging Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The brain and neuroimaging devices market size has grown strongly in recent years. It will grow from $37.53 billion in 2023 to $39.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to diagnosis and treatment of neurological disorders, aging population, brain mapping and connectivity research, emerging markets growth.

The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $48.66 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to regulatory support, personalized medicine, targeted therapies, value-based healthcare. Major trends in the forecast period include high-resolution imaging, multimodal imaging, wearable neuroimaging, connectivity and functional imaging.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3290&type=smp

Market Segmentation:
The main imaging types of brain and neuroimaging devices are functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is a type of imaging technique that measures the metabolic activity of the cells of body tissues using radioactive substances. The various applications of brain and neuroimaging devices are Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and other applications that are used in hospitals, diagnostic centers, and ambulatory surgical centers.

Major Driver - Increase Incidences Of Neurological Disorders In Brain And Neuroimaging Devices Market
An increase in the incidence of neurological disorders is expected to drive the market. According to a report by the European Academy of Neurology, 1 in 3 people in 2022 are affected by a neurological disease and the number of deaths due to neurological disorders increased by almost 40% in the last 30 years. Brain and neuroimaging devices are used to diagnose neurological disorders increasing the survival rate and management of the disease. This increasing incidence rate is expected to drive the brain and neuroimaging devices market.

Competitive Landscape:
Major companies operating in the brain and neuroimaging devices market include GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, Medtronic Plc., EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Varian Medical Systems, Toshiba Corporation, Shimadzu Corporation, Agilent Technologies Inc., Waters Corporation, Bruker Corporation, PerkinElmer Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Hologic Inc., Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Intranerve Neuroscience Holdings LLC., Nuvasive Inc., SpecialtyCare Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Top Trend - Technological Advancements In Portable Brain Scanners For Brain And Neuroimaging Devices Market
Companies and researchers are focusing on developing portable brain scanners that are expected to revolutionize brain imaging by lowering the cost of devices, making them affordable and accessible to all. EMVision Medical Devices and researchers at Queensland University have developed a portable brain scanner technology that enables brain scanning to be performed at almost any location. Researchers at University College London have developed a portable MEG brain scanner that is lightweight, worn like just a helmet but can measure brain activity even as people make natural movements, providing improved imaging opportunities for patients with disorders that cause unprompted body movements, such as epilepsy.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Brain And Neuroimaging Devices Market Characteristics
3. Brain And Neuroimaging Devices Market Trends And Strategies
4. Brain And Neuroimaging Devices Market - Macro Economic Scenario
5. Brain And Neuroimaging Devices Market Size And Growth
…..
27. Brain And Neuroimaging Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.